Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$3.03B |
 |
Anavex Life SciencesAVXL |
$18,000 |
 |
AmgenAMGN |
-$168M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Jimenez Freddy A. | Dec 4, 2025 | Sell | 4,166 | $29.095 | $120,000 |
| Wright Richard M. | Nov 13, 2025 | Sell | 49,298 | $24.0005 | $1.2M |
| Jimenez Freddy A. | Aug 13, 2025 | Sell | 430 | $25.415 | $11,000 |
| Jimenez Freddy A. | Aug 13, 2025 | Sell | 341 | $23.9515 | $8,200 |
| Marucci Anthony S | Nov 11, 2024 | Buy | 11,500 | $26.82 | $310,000 |
| Martin Samuel Bates | Jun 14, 2024 | Sell | 17,172 | $35.4248 | $610,000 |
| Crowley Elizabeth | Jun 14, 2024 | Sell | 30,000 | $34.8654 | $1M |
FAQ - Insider Transactions
The most recent insider transaction for Celldex Therapeutics was conducted by Jimenez Freddy A., who sold 4,166 shares on December 4, 2025 at a price of $29.10 per share.
Marucci Anthony S has bought the most CLDX stock in the last 2 years, with a total value of $310,000.
Wright Richard M. has sold the most CLDX stock in the last 2 years, with a total value of $1.2M.
The total value of insider transactions for Celldex Therapeutics in the last 2 years is negative, amounting to -$2.7M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Celldex Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
